• Explore /
  • Poster
  • / Can immune therapy prevent pre-clinical cancer from progression? The impact of immune therapy on secondary cancer incidence.

Can immune therapy prevent pre-clinical cancer from progression? The impact of immune therapy on secondary cancer incidence.

Abstract Poster

Authors

null

Bridget Adcock

Cleveland Clinic Foundation, Cleveland, OH

Bridget Adcock , Heya Batah , Monica Lee , Preeyal Patel , Meera Patel , Hadil Zureigat , Ahmed Hassan , Daniel Paul Nurse , Asad Rauf , Jacqulyn Tomer , Austin Ingraham , Douglas Robert Hoen , Emily Craig Zabor , Moaath Khader Mustafa Ali

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Other IO-Related Topics

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 2651)

DOI

10.1200/JCO.2024.42.16_suppl.2651

Abstract #

2651

Poster Bd #

130

Abstract Disclosures

Similar Posters

First Author: Teerada Siripoon

First Author: Marouane Maaroufi

First Author: Nashat Gabrail

First Author: Alireza Mansouri